Preserving the Practice of Urology in California Since 1986

PSA Screening Legislation in CA

CUA launched the effort for PSA Screening Legislation in 2017 resulting in AB 1520 - a bill that will save lives and help lessen healthcare disparities

Responsive to Members

CUA acts as a "watch-dog" vigilantly watching out against attacks on our our freedom to practice and fighting burdensome regulations.

CUA has teamed up with Zero Prostate Cancer to support prostate cancer awareness and patient care.

November is Urological Health Month

Use our poster to convey a positive message of appreciation for Urologists and staff during the month of November.

The Power of U

Volunteer driven and led, the CUA works actively on behalf of its Members!

Frontlines

CUA Coalition supports HR56 -Resolution advancing Prostate Cancer Awareness

June 30, 2021

The CUA wishes to thank and acknowledge Assemblymember Marc Levine for introducing HR56 proclaiming September 2021 as Prostate Cancer Awareness…

Read More

OP-ED: California lawmakers should address health disparities, stem rise in prostate cancer

May 20, 2021

Below is an Op-ed article authored by Peter N. Bretan, Jr., MD (CUA Past-President and CMA President) published by The…

Read More

Assembly Bill 1520 Passes Health Committee Hearing

April 28, 2021

Success: Assembly Bill 1520 Passes Health Committee Hearing We are pleased to announce that the Assembly Health Committee has passed…

Read More

CMA Council on Legislation Report –March 11 2021

March 31, 2021

Report: CMA Council on Legislation By Dr. John Lam, CUA Pres-Elect & Rep to CMA The following is a comprehensive…

Read More

CUA 4 year PSA Leg effort results in AB 1520

March 10, 2021

PSA screening legislation is moving forward In 2017 CUA launched an effort to seek statewide legislation to preserve coverage for…

Read More

Credits for CA Fluoroscopy License renewal during 2020 virtual meeting

October 8, 2020

Earn CEU and CME at no extra charge The CUA is pleased to announce that it has been able to…

Read More

Synopsis: AUA Advocacy Summit 2020

October 2, 2020

By Dr. John Lam, CUA Secretary The following is a comprehensive summary of the Annual Advocacy Summit hosted by the…

Read More

CMA President Peter N. Bretan, Jr., M.D., statement on George Floyd death

June 5, 2020

California Medical Association (CMA) President Peter N. Bretan, Jr., M.D., released the following statement in response to the death of…

Read More

Message from the President – Matt Cooperberg, MD

March 24, 2020

Greetings to all California urologists: The COVID-19 pandemic is easily on track to effect the greatest social upheaval the world…

Read More

Special Bulletin – Telehealth Alert

March 22, 2020

Dear Members and Colleagues, The CUA wishes to share a recent Telehealth Alert from Mark Painter at PRS as well…

Read More

CUA Annual Meeting 2021
@ WSAUA Meeting, Indian Wells, CA, October 31 - Nov. 4

  • All urologists & health pros invited
  • Date & Time tbd

With overwhelming, bipartisan support #AB347 passed the California Legislature and now @CAGovernor has signed #steptherapyreform into #CA law!

Great news for patients in #CA as #AB347 to reform #steptherapy insurance protocols is now law! TY @DrArambulaAD31 for your leadership and @CAGovernor for your signature!

Prostate Cancer Awareness Month – Clinical Webinar on “Treatment of Prostate Cancer from the Oncologist and Urologist Perspective” - Dr. John Lam on panel
September 22 @ 5:30 pm - 6:30 pm - register free
https://moasc.org/event/prostate-cancer-awareness-month-clinical-webinar-on-treatment-of-prostate-cancer-from-the-oncologist-and-urologist-perspective/

#AB347 puts prescribing back in the hands of doctors and their patients without inappropriate interference from insurers. Please support #steptherapyreform in #California! @drarambulaAD31 @SenToniAtkins @ScottWilkCA

According to a recent study, Under H. R. 3, only 2 of the 16 medicines produced in California from venture partnerships would have come to market, an 88% reduction. Californians need access to lifesaving treatments and cure thanks @RepCardenas for putting patients first.

According to a recent study, Under H. R. 3, only 2 of the 16 medicines produced in California from venture partnerships would have come to market, an 88% reduction. Californians need access to lifesaving treatments and cure thanks @ScottPetersSD for putting patients first.

Drug pricing proposals in #HR3, including foreign reference pricing and #medicare drug price negotiation, threaten lifesaving treatments and cures. Thank you, @ScottPetersSD for standing up for CA patients.

We commend @RepKatiePorter for raising concerns about the Quality Adjusted Life Years (QALY) methodology. We know the QALY discriminates against Californians with disabilities, patients with cancer or a rare disease, and seniors. Federal policymakers must avoid ICER and the QALY.

Thank you Assemblymember Marc Levine @MarcLevine for introducing HR56 proclaiming September 2021 as Prostate Cancer Awareness Month in California.

“Unfortunately, sometimes that critical medication selection is taken away from physicians by insurance companies that want patients to try other medications first” #steptherapy #AB347 @CalMatters https://bit.ly/3quDS2y

Load More...